10:55 AM EST, 02/10/2025 (MT Newswires) -- (Updates with Springworks response in the final paragraph.)

Spingworks Therapeutics (SWTX) is in advanced talks to be acquired by Merck KGaA, Reuters reported Monday, citing unnamed people familiar with the matter.

According to the report, a deal could be signed in the coming weeks if the talks are successful.

Springworks declined to comment when contacted by MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 52.46, Change: +12.18, Percent Change: +30.24